nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.164	0.216	CbGbCtD
Dihydrocodeine—CYP3A4—Triamcinolone—psoriatic arthritis	0.124	0.164	CbGbCtD
Dihydrocodeine—CYP3A4—Betamethasone—psoriatic arthritis	0.107	0.14	CbGbCtD
Dihydrocodeine—CYP3A4—Prednisolone—psoriatic arthritis	0.105	0.139	CbGbCtD
Dihydrocodeine—CYP3A4—Prednisone—psoriatic arthritis	0.0993	0.131	CbGbCtD
Dihydrocodeine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0975	0.129	CbGbCtD
Dihydrocodeine—CYP3A4—Dexamethasone—psoriatic arthritis	0.062	0.0817	CbGbCtD
Dihydrocodeine—Hepatic enzyme increased—Auranofin—psoriatic arthritis	0.0129	0.0533	CcSEcCtD
Dihydrocodeine—Withdrawal syndrome—Prednisone—psoriatic arthritis	0.00674	0.028	CcSEcCtD
Dihydrocodeine—Angioedema—Auranofin—psoriatic arthritis	0.00486	0.0201	CcSEcCtD
Dihydrocodeine—Constipation—Auranofin—psoriatic arthritis	0.00371	0.0154	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00355	0.0147	CcSEcCtD
Dihydrocodeine—Urticaria—Auranofin—psoriatic arthritis	0.00344	0.0143	CcSEcCtD
Dihydrocodeine—Abdominal pain—Auranofin—psoriatic arthritis	0.00343	0.0142	CcSEcCtD
Dihydrocodeine—Pruritus—Auranofin—psoriatic arthritis	0.00307	0.0127	CcSEcCtD
Dihydrocodeine—Diarrhoea—Auranofin—psoriatic arthritis	0.00297	0.0123	CcSEcCtD
Dihydrocodeine—Affect lability—Prednisolone—psoriatic arthritis	0.00277	0.0115	CcSEcCtD
Dihydrocodeine—Vomiting—Auranofin—psoriatic arthritis	0.00276	0.0114	CcSEcCtD
Dihydrocodeine—Rash—Auranofin—psoriatic arthritis	0.00273	0.0113	CcSEcCtD
Dihydrocodeine—Dermatitis—Auranofin—psoriatic arthritis	0.00273	0.0113	CcSEcCtD
Dihydrocodeine—Mood swings—Prednisolone—psoriatic arthritis	0.00266	0.0111	CcSEcCtD
Dihydrocodeine—Nausea—Auranofin—psoriatic arthritis	0.00258	0.0107	CcSEcCtD
Dihydrocodeine—Affect lability—Triamcinolone—psoriatic arthritis	0.00255	0.0106	CcSEcCtD
Dihydrocodeine—Affect lability—Methylprednisolone—psoriatic arthritis	0.00254	0.0105	CcSEcCtD
Dihydrocodeine—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.00249	0.0103	CcSEcCtD
Dihydrocodeine—Mood swings—Triamcinolone—psoriatic arthritis	0.00245	0.0102	CcSEcCtD
Dihydrocodeine—Mood swings—Methylprednisolone—psoriatic arthritis	0.00245	0.0101	CcSEcCtD
Dihydrocodeine—Affect lability—Dexamethasone—psoriatic arthritis	0.00231	0.00958	CcSEcCtD
Dihydrocodeine—Affect lability—Betamethasone—psoriatic arthritis	0.00231	0.00958	CcSEcCtD
Dihydrocodeine—Mood swings—Dexamethasone—psoriatic arthritis	0.00222	0.00922	CcSEcCtD
Dihydrocodeine—Mood swings—Betamethasone—psoriatic arthritis	0.00222	0.00922	CcSEcCtD
Dihydrocodeine—Affect lability—Prednisone—psoriatic arthritis	0.00201	0.00834	CcSEcCtD
Dihydrocodeine—Mood swings—Prednisone—psoriatic arthritis	0.00194	0.00803	CcSEcCtD
Dihydrocodeine—Hallucination—Methylprednisolone—psoriatic arthritis	0.00178	0.00737	CcSEcCtD
Dihydrocodeine—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00162	0.00672	CcSEcCtD
Dihydrocodeine—Mood swings—Methotrexate—psoriatic arthritis	0.00162	0.00671	CcSEcCtD
Dihydrocodeine—Hallucination—Dexamethasone—psoriatic arthritis	0.00162	0.0067	CcSEcCtD
Dihydrocodeine—Hallucination—Betamethasone—psoriatic arthritis	0.00162	0.0067	CcSEcCtD
Dihydrocodeine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00161	0.00669	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00161	0.00667	CcSEcCtD
Dihydrocodeine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00156	0.00649	CcSEcCtD
Dihydrocodeine—Angioedema—Prednisolone—psoriatic arthritis	0.00155	0.00642	CcSEcCtD
Dihydrocodeine—Vertigo—Prednisolone—psoriatic arthritis	0.00152	0.00631	CcSEcCtD
Dihydrocodeine—Angiopathy—Dexamethasone—psoriatic arthritis	0.00147	0.00611	CcSEcCtD
Dihydrocodeine—Angiopathy—Betamethasone—psoriatic arthritis	0.00147	0.00611	CcSEcCtD
Dihydrocodeine—Convulsion—Prednisolone—psoriatic arthritis	0.00147	0.00609	CcSEcCtD
Dihydrocodeine—Angioedema—Triamcinolone—psoriatic arthritis	0.00142	0.0059	CcSEcCtD
Dihydrocodeine—Angioedema—Methylprednisolone—psoriatic arthritis	0.00142	0.00589	CcSEcCtD
Dihydrocodeine—Hallucination—Prednisone—psoriatic arthritis	0.00141	0.00584	CcSEcCtD
Dihydrocodeine—Vertigo—Triamcinolone—psoriatic arthritis	0.0014	0.00581	CcSEcCtD
Dihydrocodeine—Vertigo—Methylprednisolone—psoriatic arthritis	0.0014	0.00579	CcSEcCtD
Dihydrocodeine—Convulsion—Triamcinolone—psoriatic arthritis	0.00135	0.0056	CcSEcCtD
Dihydrocodeine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00135	0.00559	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00134	0.00554	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00131	0.00545	CcSEcCtD
Dihydrocodeine—Dry mouth—Triamcinolone—psoriatic arthritis	0.0013	0.00538	CcSEcCtD
Dihydrocodeine—Angioedema—Betamethasone—psoriatic arthritis	0.00129	0.00536	CcSEcCtD
Dihydrocodeine—Angioedema—Dexamethasone—psoriatic arthritis	0.00129	0.00536	CcSEcCtD
Dihydrocodeine—Angiopathy—Prednisone—psoriatic arthritis	0.00128	0.00532	CcSEcCtD
Dihydrocodeine—Confusional state—Methylprednisolone—psoriatic arthritis	0.00128	0.00531	CcSEcCtD
Dihydrocodeine—Immune system disorder—Prednisone—psoriatic arthritis	0.00128	0.0053	CcSEcCtD
Dihydrocodeine—Vertigo—Dexamethasone—psoriatic arthritis	0.00127	0.00527	CcSEcCtD
Dihydrocodeine—Vertigo—Betamethasone—psoriatic arthritis	0.00127	0.00527	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00125	0.00516	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00124	0.00516	CcSEcCtD
Dihydrocodeine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00124	0.00515	CcSEcCtD
Dihydrocodeine—Mental disorder—Prednisone—psoriatic arthritis	0.00124	0.00514	CcSEcCtD
Dihydrocodeine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00123	0.00511	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00123	0.0051	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00123	0.00509	CcSEcCtD
Dihydrocodeine—Convulsion—Dexamethasone—psoriatic arthritis	0.00122	0.00508	CcSEcCtD
Dihydrocodeine—Convulsion—Betamethasone—psoriatic arthritis	0.00122	0.00508	CcSEcCtD
Dihydrocodeine—Hypotension—Methylprednisolone—psoriatic arthritis	0.00119	0.00492	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00117	0.00484	CcSEcCtD
Dihydrocodeine—Urethral disorder—Methotrexate—psoriatic arthritis	0.00116	0.0048	CcSEcCtD
Dihydrocodeine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00114	0.00474	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00114	0.00473	CcSEcCtD
Dihydrocodeine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00114	0.00472	CcSEcCtD
Dihydrocodeine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00113	0.0047	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00113	0.00469	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00113	0.00469	CcSEcCtD
Dihydrocodeine—Angioedema—Prednisone—psoriatic arthritis	0.00112	0.00467	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00112	0.00463	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00112	0.00463	CcSEcCtD
Dihydrocodeine—Vertigo—Prednisone—psoriatic arthritis	0.00111	0.00459	CcSEcCtD
Dihydrocodeine—Urticaria—Prednisolone—psoriatic arthritis	0.0011	0.00456	CcSEcCtD
Dihydrocodeine—Hypotension—Dexamethasone—psoriatic arthritis	0.00108	0.00447	CcSEcCtD
Dihydrocodeine—Hypotension—Betamethasone—psoriatic arthritis	0.00108	0.00447	CcSEcCtD
Dihydrocodeine—Angiopathy—Methotrexate—psoriatic arthritis	0.00107	0.00445	CcSEcCtD
Dihydrocodeine—Immune system disorder—Methotrexate—psoriatic arthritis	0.00107	0.00443	CcSEcCtD
Dihydrocodeine—Convulsion—Prednisone—psoriatic arthritis	0.00107	0.00442	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00107	0.00442	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00105	0.00435	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00105	0.00434	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00104	0.00432	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00104	0.0043	CcSEcCtD
Dihydrocodeine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00104	0.0043	CcSEcCtD
Dihydrocodeine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00104	0.0043	CcSEcCtD
Dihydrocodeine—Mental disorder—Methotrexate—psoriatic arthritis	0.00104	0.00429	CcSEcCtD
Dihydrocodeine—Urticaria—Triamcinolone—psoriatic arthritis	0.00101	0.00419	CcSEcCtD
Dihydrocodeine—Urticaria—Methylprednisolone—psoriatic arthritis	0.00101	0.00418	CcSEcCtD
Dihydrocodeine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.001	0.00416	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000996	0.00413	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000996	0.00413	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000985	0.00409	CcSEcCtD
Dihydrocodeine—Skin disorder—Prednisone—psoriatic arthritis	0.000976	0.00405	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000971	0.00403	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000951	0.00394	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000951	0.00394	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000943	0.00391	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000943	0.00391	CcSEcCtD
Dihydrocodeine—Vertigo—Methotrexate—psoriatic arthritis	0.000924	0.00383	CcSEcCtD
Dihydrocodeine—Urticaria—Betamethasone—psoriatic arthritis	0.000917	0.0038	CcSEcCtD
Dihydrocodeine—Urticaria—Dexamethasone—psoriatic arthritis	0.000917	0.0038	CcSEcCtD
Dihydrocodeine—Dizziness—Prednisolone—psoriatic arthritis	0.000914	0.00379	CcSEcCtD
Dihydrocodeine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000912	0.00378	CcSEcCtD
Dihydrocodeine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000912	0.00378	CcSEcCtD
Dihydrocodeine—Paraesthesia—Prednisone—psoriatic arthritis	0.000902	0.00374	CcSEcCtD
Dihydrocodeine—Pruritus—Triamcinolone—psoriatic arthritis	0.0009	0.00373	CcSEcCtD
Dihydrocodeine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000898	0.00372	CcSEcCtD
Dihydrocodeine—Convulsion—Methotrexate—psoriatic arthritis	0.000891	0.0037	CcSEcCtD
Dihydrocodeine—Rash—Prednisolone—psoriatic arthritis	0.000872	0.00362	CcSEcCtD
Dihydrocodeine—Dermatitis—Prednisolone—psoriatic arthritis	0.000871	0.00361	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00087	0.00361	CcSEcCtD
Dihydrocodeine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000868	0.0036	CcSEcCtD
Dihydrocodeine—Headache—Prednisolone—psoriatic arthritis	0.000866	0.00359	CcSEcCtD
Dihydrocodeine—Constipation—Prednisone—psoriatic arthritis	0.000859	0.00356	CcSEcCtD
Dihydrocodeine—Confusional state—Methotrexate—psoriatic arthritis	0.000847	0.00351	CcSEcCtD
Dihydrocodeine—Dizziness—Triamcinolone—psoriatic arthritis	0.000841	0.00349	CcSEcCtD
Dihydrocodeine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000839	0.00348	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000828	0.00343	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000823	0.00342	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000822	0.00341	CcSEcCtD
Dihydrocodeine—Nausea—Prednisolone—psoriatic arthritis	0.000821	0.00341	CcSEcCtD
Dihydrocodeine—Pruritus—Dexamethasone—psoriatic arthritis	0.000816	0.00339	CcSEcCtD
Dihydrocodeine—Pruritus—Betamethasone—psoriatic arthritis	0.000816	0.00339	CcSEcCtD
Dihydrocodeine—Skin disorder—Methotrexate—psoriatic arthritis	0.000816	0.00338	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000812	0.00337	CcSEcCtD
Dihydrocodeine—Vomiting—Triamcinolone—psoriatic arthritis	0.000808	0.00335	CcSEcCtD
Dihydrocodeine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000807	0.00335	CcSEcCtD
Dihydrocodeine—Rash—Triamcinolone—psoriatic arthritis	0.000802	0.00332	CcSEcCtD
Dihydrocodeine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000801	0.00332	CcSEcCtD
Dihydrocodeine—Rash—Methylprednisolone—psoriatic arthritis	0.0008	0.00332	CcSEcCtD
Dihydrocodeine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000799	0.00331	CcSEcCtD
Dihydrocodeine—Urticaria—Prednisone—psoriatic arthritis	0.000798	0.00331	CcSEcCtD
Dihydrocodeine—Headache—Triamcinolone—psoriatic arthritis	0.000797	0.0033	CcSEcCtD
Dihydrocodeine—Headache—Methylprednisolone—psoriatic arthritis	0.000795	0.0033	CcSEcCtD
Dihydrocodeine—Abdominal pain—Prednisone—psoriatic arthritis	0.000794	0.00329	CcSEcCtD
Dihydrocodeine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000789	0.00327	CcSEcCtD
Dihydrocodeine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000789	0.00327	CcSEcCtD
Dihydrocodeine—Hypotension—Methotrexate—psoriatic arthritis	0.000785	0.00325	CcSEcCtD
Dihydrocodeine—Dizziness—Dexamethasone—psoriatic arthritis	0.000763	0.00316	CcSEcCtD
Dihydrocodeine—Dizziness—Betamethasone—psoriatic arthritis	0.000763	0.00316	CcSEcCtD
Dihydrocodeine—Nausea—Triamcinolone—psoriatic arthritis	0.000755	0.00313	CcSEcCtD
Dihydrocodeine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000754	0.00313	CcSEcCtD
Dihydrocodeine—Nausea—Methylprednisolone—psoriatic arthritis	0.000754	0.00313	CcSEcCtD
Dihydrocodeine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000749	0.0031	CcSEcCtD
Dihydrocodeine—Somnolence—Methotrexate—psoriatic arthritis	0.000746	0.0031	CcSEcCtD
Dihydrocodeine—Vomiting—Dexamethasone—psoriatic arthritis	0.000734	0.00304	CcSEcCtD
Dihydrocodeine—Vomiting—Betamethasone—psoriatic arthritis	0.000734	0.00304	CcSEcCtD
Dihydrocodeine—Rash—Dexamethasone—psoriatic arthritis	0.000727	0.00302	CcSEcCtD
Dihydrocodeine—Rash—Betamethasone—psoriatic arthritis	0.000727	0.00302	CcSEcCtD
Dihydrocodeine—Dermatitis—Betamethasone—psoriatic arthritis	0.000727	0.00301	CcSEcCtD
Dihydrocodeine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000727	0.00301	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000725	0.00301	CcSEcCtD
Dihydrocodeine—Headache—Dexamethasone—psoriatic arthritis	0.000723	0.003	CcSEcCtD
Dihydrocodeine—Headache—Betamethasone—psoriatic arthritis	0.000723	0.003	CcSEcCtD
Dihydrocodeine—Pruritus—Prednisone—psoriatic arthritis	0.000711	0.00295	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000692	0.00287	CcSEcCtD
Dihydrocodeine—Diarrhoea—Prednisone—psoriatic arthritis	0.000687	0.00285	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000687	0.00285	CcSEcCtD
Dihydrocodeine—Nausea—Betamethasone—psoriatic arthritis	0.000685	0.00284	CcSEcCtD
Dihydrocodeine—Nausea—Dexamethasone—psoriatic arthritis	0.000685	0.00284	CcSEcCtD
Dihydrocodeine—Urticaria—Methotrexate—psoriatic arthritis	0.000667	0.00277	CcSEcCtD
Dihydrocodeine—Dizziness—Prednisone—psoriatic arthritis	0.000664	0.00276	CcSEcCtD
Dihydrocodeine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000664	0.00275	CcSEcCtD
Dihydrocodeine—Vomiting—Prednisone—psoriatic arthritis	0.000639	0.00265	CcSEcCtD
Dihydrocodeine—Rash—Prednisone—psoriatic arthritis	0.000634	0.00263	CcSEcCtD
Dihydrocodeine—Dermatitis—Prednisone—psoriatic arthritis	0.000633	0.00262	CcSEcCtD
Dihydrocodeine—Headache—Prednisone—psoriatic arthritis	0.000629	0.00261	CcSEcCtD
Dihydrocodeine—Nausea—Prednisone—psoriatic arthritis	0.000597	0.00248	CcSEcCtD
Dihydrocodeine—Pruritus—Methotrexate—psoriatic arthritis	0.000594	0.00246	CcSEcCtD
Dihydrocodeine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000575	0.00238	CcSEcCtD
Dihydrocodeine—Dizziness—Methotrexate—psoriatic arthritis	0.000555	0.0023	CcSEcCtD
Dihydrocodeine—Vomiting—Methotrexate—psoriatic arthritis	0.000534	0.00221	CcSEcCtD
Dihydrocodeine—Rash—Methotrexate—psoriatic arthritis	0.000529	0.0022	CcSEcCtD
Dihydrocodeine—Dermatitis—Methotrexate—psoriatic arthritis	0.000529	0.00219	CcSEcCtD
Dihydrocodeine—Headache—Methotrexate—psoriatic arthritis	0.000526	0.00218	CcSEcCtD
Dihydrocodeine—Nausea—Methotrexate—psoriatic arthritis	0.000499	0.00207	CcSEcCtD
